HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts

Journal of Clinical Investigation

Volumn 122, Issue 10, 2012, Pages 3603-3617

  Ko, Song Yi ^a   Barengo, Nicolas ^a   Ladanyi, Andras ^b   Lee, Ju Seog ^a   Marini, Frank ^c   Lengyel, Ernst ^b   Naora, Honami ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR HOXA9; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN A;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OVARY CARCINOMA; PARACRINE SIGNALING; PERITONEAL FIBROBLAST; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; TRANSCRIPTION INITIATION; TUMOR XENOGRAFT;

ADIPOSE TISSUE; ANIMALS; CARCINOMA; CELL DIFFERENTIATION; CELL DIVISION; CHEMOKINE CXCL12; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; INTERLEUKIN-6; KAPLAN-MEIER ESTIMATE; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PARACRINE COMMUNICATION; PERITONEAL NEOPLASMS; PERITONEUM; PROGNOSIS; TRANSFORMING GROWTH FACTOR BETA2; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84867163385     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI62229     Document Type: Article

References (58)

1. Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177(3):1053-1064.
2. Naora H, Montell DJ. Ovarian cancer metastasis: Integrating insights from disparate model organisms. Nat Rev Cancer. 2005;5(5):355-366. (Pubitemid 40637827)
3. Clements PB, Young RH. Atlas of Gynecologic Surgical Pathology. Philadelphia, Pennsylvania, USA: WB Saunders; 2000.
4. Pearson JC, Lemons D, McGinnis W. Modulating HOX gene functions during animal body patterning. Nat Rev Genet. 2005;6(12):893-904. (Pubitemid 41782157)
5. Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer. 2002;2(10):777-785. (Pubitemid 37328912)
6. Samuel S, Naora H. Homeobox gene expression in cancer: Insights from developmental regulation and deregulation. Eur J Cancer. 2005;41(16):2428-2437. (Pubitemid 41540620)
7. Robson EJ, He SJ, Eccles MR. A panorama of PAX genes in cancer and development. Nat Rev Cancer. 2006;6(1):52-62. (Pubitemid 43053651)
8. Hsieh-Li HM, et al. Hoxa 11 structure, extensive antisense transcription, and function in male and female fertility. Development. 1995;121(5):1373-1385.
9. Benson GV, et al. Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development. 1996;122(9):2687-2696. (Pubitemid 26326501)
10. Taylor HS, Vanden Heuvel GB, Igarashi P. A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biol Reprod. 1997;57(6):1338-1345. (Pubitemid 27516636)
11. Cheng W, Liu J, Yoshida H, Rosen D, Naora H. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat Med. 2005;11(5):531-537. (Pubitemid 40685976)
12. Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol. 2006;1:119-150.
13. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392-401.
14. Direkze NC, et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 2004;64(23):8492-8495. (Pubitemid 39552057)
15. Orimo A, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121(3):335-348. (Pubitemid 40692295)
16. Spaeth EL, et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One. 2009;4(4):e4992.
17. Quante M, et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell. 2011;19(2):257-272.
18. Kojima Y, et al. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A. 2010;107(46):20009-20014.
19. Tothill RW, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 2008;14(16):5198- 5208.
20. Petersen OW, et al. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am J Pathol. 2003;162(2):391-402. (Pubitemid 36267847)
21. Zhang Y, et al. Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer Lett. 2011;303(1):47-55.
22. McLean K, et al. Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest. 2011;121(8):3206-3219.
23. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119(11):2204-2213. (Pubitemid 43960310)
24. Zuk PA, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279-4295. (Pubitemid 35471185)
25. Bascom CC, et al. Complex regulation of transforming growth factor β1, β2 and β3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors β1 and β2. Mol Cell Biol. 1989;9(12):5508-5515. (Pubitemid 20004369)
26. Sanford LP, et al. TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development. 1997;124(13):2659-2670. (Pubitemid 27341765)
27. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. Immunohistochemical localization of TGFβ1, TGFβ2 and TGFβ3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol. 1991;115(4):1091-1105. (Pubitemid 21909956)
28. Bartlett JM, et al. Transforming growth factor-β isoform expression in human ovarian tumors. Eur J Cancer. 1997;33(14):2397-2403. (Pubitemid 28129184)
29. Abendstein B, et al. Regulation of transforming growth factor-β secretion by human peritoneal mesothelial and ovarian carcinoma cells. Cytokine. 2000;12(7):1115-1119. (Pubitemid 30479497)
30. Nemunaitis J, et al. Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer. J Clin Oncol. 2006;24(29):4721-4730. (Pubitemid 46630936)
31. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871-890.
32. Lopez-Casillas F, Wrana JL, Massague J. Betaglycan presents ligand to the TGFβ signaling receptor. Cell. 1993;73(7):1435-1444. (Pubitemid 23201155)
33. Hempel N, et al. Loss of betaglycan expression in ovarian cancer: role in motility and invasion. Cancer Res. 2007;67(11):5231-5238. (Pubitemid 46997261)
34. Zhao M, Dumur CI, Holt SE, Beckman MJ, Elmore LW. Multipotent adipose stromal cells and breast cancer development: think globally, act locally. Mol Carcinog. 2010;49(11):923-927.
35. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003;33(6):919-926. (Pubitemid 37543568)
36. Hara F, et al. A homeobox gene related to Drosophila Distal-less promotes ovarian tumorigenicity by inducing expression of vascular endothelial growth factor and fibroblast growth factor-2. Am J Pathol. 2007;170(5):1594-1606. (Pubitemid 47339304)
37. Mace KA, et al. HOXA3 modulates injury-induced mobilization and recruitment of bone marrow-derived cells. Stem Cells. 2009;27(7):1654-1665.
38. Muratovska A, Zhou C, He S, Goodyer P, Eccles MR. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene. 2003;22(39):7989-7997. (Pubitemid 37179944)
39. Coletta RD, et al. The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1. Proc Natl Acad Sci U S A. 2004;101(17):6478-6483. (Pubitemid 38585999)
40. Trinh BQ, Barengo N, Naora H. Homeodomain protein DLX4 counteracts key transcriptional control mechanisms of the TGF-β- cytostatic program and blocks the antiproliferative effect of TGF-β. Oncogene. 2011;30(24):2718-2729.
41. Bahrani-Mostafavi Z, et al. Correlation analysis of HOX, ErbB and IGFBP family gene expression in ovarian cancer. Cancer Invest. 2008;26(10):990-998.
42. Montavon C, et al. Prognostic and diagnostic significance of DNA methylation patterns in high-grade serous ovarian cancer. Gynecol Oncol. 2012;124(3):582-588.
43. Wu Q, et al. DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1 and CRABP1 as novel targets. Mol Cancer. 2007;6:45.
44. Daftary GS, Troy PJ, Bagot CN, Young SL, Taylor HS. Direct regulation of β3-integrin subunit gene expression by HOXA10 in endometrial cells. Mol Endocrinol. 2002;16(3):571-579. (Pubitemid 34214576)
45. Ko SY, Lengyel E, Naora H. The Müllerian HOXA10 gene promotes growth of ovarian surface epithelial cells by stimulating epithelial-stromal interactions. Mol Cell Endocrinol. 2010;317(1-2):112-119.
46. Yoshida H, Broaddus R, Cheng W, Xie S, Naora H. Deregulation of the HOXA10 homeobox gene in endometrial carcinoma: Role in epithelial-mesenchymal transition. Cancer Res. 2006;66(2):889-897. (Pubitemid 43165955)
47. Kaur S, et al. Beta3-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer. Am J Pathol. 2009;175(5):2184-2196.
48. Taylor HS, Arici A, Olive D, Igarashi P. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest. 1998;101(7):1379-1384. (Pubitemid 28166835)
49. Taylor HS, Igarashi P, Olive DL, Arici A. Sex steroids mediate HOXA11 expression in the human peri-implantation endometrium. J Clin Endocrinol Metab. 1999;84(3):1129-1135. (Pubitemid 29138254)
50. Carson DD, et al. Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod. 2002;8(9):871-879. (Pubitemid 35012476)
51. Golub TR, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286(5439):531-537.
52. Kroon E, et al. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 1998;17(13):3714-3725. (Pubitemid 28327389)
53. Thorsteinsdottir U, et al. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood. 2002;99(1):121-129.
54. Langer JC, Henckaerts E, Orenstein J, Snoeck HW. Quantitative trait analysis reveals transforming growth factor-β2 as a positive regulator of early hematopoietic progenitor and stem cell function. J Exp Med. 2004;199(1):5-14. (Pubitemid 38076473)
55. Gilbert PM, et al. HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. J Clin Invest. 2010;120(5):1535-1550.
56. Son JW, et al. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients. Cancer Lett. 2011;311(1):29-37.
57. Kenny HA, Krausz T, Yamada SD, Lengyel E. Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extracellular matrices on adhesion and invasion of ovarian cancer cells to the omentum. Int J Cancer. 2007;121(7):1463-1472. (Pubitemid 47328704)
58. b-tsA58 mice for studies of angiogenesis and metastasis. Cancer Res. 2003;63(11):2971-2976.